FASEB J.
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Steranka, L. R.
Right arrow Articles by Burch, R. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Steranka, L. R.
Right arrow Articles by Burch, R. M.

The FASEB Journal, Vol 3, 2019-2025, Copyright © 1989 by The Federation of American Societies for Experimental Biology


REVIEWS

Antagonists of B2 bradykinin receptors

LR Steranka, SG Farmer and RM Burch
Nova Pharmaceutical Corporation, Baltimore, Maryland 21224.

Bradykinin and its active metabolites, produced by kallikreins at their sites of action, potently elicit a variety of biological effects: hypotension, bronchoconstriction, gut and uterine contraction, epithelial secretion in airway, gut, and exocrine glands, vascular permeability, pain, connective tissue proliferation, cytokine release, and eicosanoid formation. These effects are mediated by at least two broad classes of receptors. The most common is the B2 subtype. The availability of competitive antagonists of B2 receptors has provided powerful tools for the study of bradykinin's actions. The significance of kinins in certain human diseases is being explored by using these agents as potential therapeutic agents. Human clinical trials are under way to test the usefulness of bradykinin receptor antagonists to treat symptoms of the common cold and the pain associated with severe burns. Trials are also being comtemplated for use in treatment of asthma.


This article has been cited by other articles:


Home page
J Clin PharmacolHome page
J. N. Sharma
Does the Kinin System Mediate in Cardiovascular Abnormalities? An Overview
J. Clin. Pharmacol., November 1, 2003; 43(11): 1187 - 1195.
[Abstract] [Full Text] [PDF]


Home page
CVIHome page
I. Rubinstein and G. W. Pedersen
Bacillus Species Are Present in Chewing Tobacco Sold in the United States and Evoke Plasma Exudation from the Oral Mucosa
Clin. Vaccine Immunol., September 1, 2002; 9(5): 1057 - 1060.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
A. Moldobaeva and E. M. Wagner
Heterogeneity of bronchial endothelial cell permeability
Am J Physiol Lung Cell Mol Physiol, September 1, 2002; 283(3): L520 - L527.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
I. Rubinstein, J. Potempa, J. Travis, and X.-P. Gao
Mechanisms Mediating Porphyromonas gingivalis Gingipain RgpA-Induced Oral Mucosa Inflammation In Vivo
Infect. Immun., February 1, 2001; 69(2): 1199 - 1201.
[Abstract] [Full Text] [PDF]


Home page
CVIHome page
I. Rubinstein
Subtilisin Increases Macromolecular Efflux from the Oral Mucosa
Clin. Vaccine Immunol., September 1, 2000; 7(5): 794 - 802.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
K. E. Loke, C. M. L. Curran, E. J. Messina, S. K. Laycock, E. G. Shesely, O. A. Carretero, and T. H. Hintze
Role of Nitric Oxide in the Control of Cardiac Oxygen Consumption in B2-Kinin Receptor Knockout Mice
Hypertension, October 1, 1999; 34(4): 563 - 567.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
I. Rubinstein, X.-P. Gao, S. Pakhlevaniants, and D. Oda
Smokeless tobacco-exposed oral keratinocytes increase macromolecular efflux from the in situ oral mucosa
Am J Physiol Regulatory Integrative Comp Physiol, January 1, 1998; 274(1): R104 - R111.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
B. Schindelholz and B. F. X. Reber
Bradykinin-Induced Collapse of Rat Pheochromocytoma (PC12) Cell Growth Cones: A Role for Tyrosine Kinase Activity
J. Neurosci., November 1, 1997; 17(21): 8391 - 8401.
[Abstract] [Full Text] [PDF]


Home page
J. Appl. Physiol.Home page
X.-P. Gao, H. Suzuki, C. O. Olopade, S. Pakhlevaniants, and I. Rubinstein
Purified ACE attenuates smokeless tobacco-induced increase in macromolecular efflux from the oral mucosa
J Appl Physiol, July 1, 1997; 83(1): 74 - 81.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
R. Veelken, A. Glabasnia, A. Stetter, K. F. Hilgers, J. F.E. Mann, and R. E. Schmieder
Epicardial Bradykinin B2 Receptors Elicit a Sympathoexcitatory Reflex in Rats
Hypertension, October 1, 1996; 28(4): 615 - 621.
[Abstract] [Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1989 by The Federation of American Societies for Experimental Biology.